Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx ...

A team of Indian American scientists led by Pallavi Gopal are working to learn more about the dynamics of a protein to help ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

A crucial link between the brain's cleaning system and deterioration of neurons associated with Alzheimer's disease has been ...

Travere Therapeutics Inc. (NASDAQ:TVTX) is a biopharmaceutical company that identifies, develops, and delivers therapies to ...

Feb. 13, 2025 — Researchers found that excessively activated neurons over time, rather than decreased neuronal activity, cause aging-related decline in brain function in ... Wednesday, April 9, 2025 ...

For many years, astrocytes were seen as simple support cells in the brain. Today, that picture is changing fast.

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

Beach season is already here and January is long gone — but it’s never too late to start (or refresh!) your fitness and wellness goals so you can feel your most confident …with or without clothes. And ...

The herb rosemary has been linked with memory—now researchers turned the compound against Alzheimer’s disease and cognitive ...

Clinical-stage biotech Neurizon Therapeutics has reported encouraging new rodent preclinical pharmacokinetic (PK) data for ...

A crucial link between the brain's cleaning system and deterioration of neurons associated with Alzheimer's disease has been ...